Industry Symposium
IS01: Preparing NSCLC for the Future of Diagnostic Biomarker Testing
Room 04
Presented by AstraZeneca
12 events found.
Industry Symposium
IS02: Precision Starts Early: The Evolving Role of Biomarker Testing in Early-Stage NSCLC
Room 05
Presented by Eli Lilly and Company
Industry Symposium
IS04: Empowering Clinicians in SCLC Management: Key Insights on Diagnosis, Treatment, and Emerging Strategies
Room 05
Presented by Daiichi Sankyo, Inc. and MSD
Featured Satellite CME Symposium
IS03: Satellite EBAC/CME Symposium by Answers in CME: Reshaping the Management of Metastatic NSCLC: Tackling HER2 Overexpression to Elevate Outcomes
Room 04
Presented by AiCME. Supported by an educational grant from Daiichi Sankyo, Inc.
Industry Symposium
IS05: What SEZ6 Says About Small Cell Lung Cancer (SCLC) and Neuroendocrine Neoplasms (NEN)
Room 04
Presented by Abbvie
Industry Symposium
IS06: Sustained Clinical Benefit in 1L ALK+ aNSCLC: How to Optimise Outcomes for Our Patients
Room 05
Presented by Pfizer
Satellite CME Symposium
IS07: Satellite EBAC/CME Symposium by PeerVoice on behalf of Bayer: Pioneering Precision: A Real-World Roadmap to Optimal Outcomes in NTRK Fusion-Positive and HER2-Mutant Advanced NSCLC
Room 05
Presented by PeerVoice. Supported by an educational grant from Bayer.
Industry Symposium
IS08: Industry Sponsored Symposium by Accord Healthcare: Recent Developments in the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer
Room 04
Presented by Accord Healthcare
Industry Symposium
IS11: Maximising a Multidisciplinary Approach: Shaping the Future of Lung Cancer Care with Immunotherapy
Room 04
Presented by AstraZeneca
Industry Symposium
IS12: Advancing EGFR-mutant NSCLC care
Room 08
Presented by Johnson & Johnson
Industry Symposium
IS13: Under the MicROScope: Focusing on ROS1+ NSCLC
Room 01
Presented by Nuvation Bio Inc.
Industry Symposium
IS14: NSCLC Reimagined: Novel Treatment Strategies in Advanced Non-Small Cell Lung Cancer
Room 05
Presented by Regeneron